Sales Operations Specialist, Docplanner

Salary not provided

Share options plan after 6 months working with us

SQL
Excel
Salesforce
Junior and Mid level
Barcelona
Docplanner

Booking platform and management software provider for doctors

Be an early applicant

Docplanner

Booking platform and management software provider for doctors

1001+ employees

HealthcareB2CB2BPersonal healthMarketplaceInternal toolsSaaS

Be an early applicant

Salary not provided

Share options plan after 6 months working with us

SQL
Excel
Salesforce
Junior and Mid level
Barcelona

1001+ employees

HealthcareB2CB2BPersonal healthMarketplaceInternal toolsSaaS

Company mission

To make the healthcare experience more human, via free doctor reviews and bookings for patients, and practice management tools for doctors.

Company mission

To make the healthcare experience more human, via free doctor reviews and bookings for patients, and practice management tools for doctors.

Top investors

Some candidates hear
back within 2 weeks

11% employee growth in 12 months

Our take

Healthcare platform Docplanner has become a major player in the European healthtech market in the decade since it was founded. The company offers a suite of administrative tools for 30M patients and around 2M doctors worldwide, including workflow digitisation and appointment booking services. The company currently operate in 13 countries, hit Unicorn status in 2021, and has been riding a recent wave of digital transformation and workforce overburdening in the healthcare sector which has spurred on demand for precisely the kind of services they provide. So it’s safe to say business is going well.

What is most compelling about Docplanner’s business journey has been its long-brewing competition with their direct competitor, the fellow Unicorn and better-funded Doctolib. The tête-à-tête with this French/German rival has seen both parties making aggressive European expansion with national acquisitions - Doctolib in Italy, France, and Germany; Docplanner in Turkey, Poland, Spain, and Latin America. With Docplanner’s 2021 acquisition of German parallel platform Jameda, however, they are making moves on Doctolib’s home turf. The company has also acquired MyDr, a leading Polsih tech solutions provider.

These broad consolidation moves represent a maturation of the healthtech market which will serve both competitors well. Docplanner is certainly a key and aggressive contender in this race - and this company isn't going anywhere any time soon.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Benefits

  • Stock Option plan
  • Flexible working hours
  • Off days package
  • English classes
  • Free health insurance & wellnes Ifeel platform (unlimited)
  • Corporate access with Andjoy colaboration
  • Additional paid holiday on your birthday to celebrate with your loved ones or to have a self-care day!
  • Working from home policy (up to 3 days per week)

Company values

  • Leave your comfort zone
  • Focus on results not tasks
  • Give feedback now, directly
  • Keep it simple
  • Do what you love
  • Hustle, hit, never quit

Funding (last 2 of 6 rounds)

May 2019

$84.2m

SERIES E

May 2017

$15.8m

SERIES D

Total funding: $133.1m

This company has top investors

Leadership

A Computer Science graduate from Warsaw University of Technology.

Previously Vice President and Chief Sales Officer at Groupon, he subsequently worked as Director for Southern European Sales at HomeAway.

Previously Senior HR Business Partner at Unilever, he went on to serve as Head of HR at GoldenLine Sp.

Jobs (30)

All locations

Software Engineering

Finance, Legal & Compliance